EE430 Cost-Effectiveness of Tremelimumab or Tremelimumab in Combination with Durvalumab Vs Durvalumab As Treatment of Advanced Hepatocellular Carcinoma
作者
Tian Tang,Lizheng Shi
出处
期刊:Value in Health [Elsevier BV] 日期:2023-06-01卷期号:26 (6): S138-S138被引量:1